Publications by authors named "S Bouee"
Objectives: Data on the economic consequences of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) are scarce in Europe. We aimed to estimate the total direct costs attributable to SLE and LN in France, at the nation-wide level.
Methods: Patients with SLE and LN were identified in the French nation-wide health insurance database (SNDS).
Background: This study aimed to describe treatment patterns in patients with myasthenia gravis (MG) in France.
Methods: A retrospective cohort analysis was performed using the French National Health Data System (SNDS) database between 2008 and 2019. MG patients were identified using ICD-10 codes during hospitalization and/or long-term disease.
A smartphone coaching program ("Bouge Grossesse") improves daily physical activity in pregnant women.
J Gynecol Obstet Hum Reprod
September 2024
Background: Physical activity has been shown to reduce obstetrical risks however pregnant women reduce their physical activity and sedentary behaviors increase.
Objective: Our aim was to evaluate the impact of a smartphone application developed to increase daily physical activity in pregnant women.
Methods: We enrolled 250 pregnant women in a prospective randomized controlled study.
Article Synopsis
- Phenylketonuria (PKU) is a serious genetic disorder that can lead to severe cognitive impairment and other health issues if untreated, prompting a study on its economic impact in France.
- A retrospective analysis was conducted using health insurance claims from the national database, identifying 3549 PKU patients and comparing their healthcare costs with matched controls in 2018.
- Results revealed that PKU patients incurred healthcare costs that were 7.7 times higher than those of non-PKU controls, mainly due to expensive pharmaceutical needs like dietary amino acid supplements, particularly impacting those diagnosed early.
Background: Specific studies on the impact of ulcerative colitis (UC) and bowel urgency (BU) on disability and quality of life (QoL) of patients on advanced therapies are missing.
Methods: Clinical and therapeutic management data were collected by Gastroenterologists from adult patients with UC treated with advanced therapies. Patients reported outcomes on QoL were collected using patient-reported questionnaires.